Update on the recommended use of hepatitis B vaccine .: HP40-174/2017E-PDF
"This statement will supplement previous NACI statements on hepatitis B (HB) by: providing an overview of current HB epidemiology in Canada and national sources of HB-related surveillance; reviewing evidence pertaining to primary and booster immunization in those vaccinated as infants and in individuals with diabetes and immunocompromising conditions; reviewing evidence pertaining to indications for HB immunoglobulin (HBIg) administration; and making recommendations regarding existing HB immunization schedules, serological testing of immunocompromised persons, and surveillance and research priorities. The primary goal of the statement is to provide further guidance on the need for re-immunization of adolescents who have received routine immunization with a HB containing vaccine in infancy"--Introd., p. 4.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.830413&sl=0
| Department/Agency |
|
|---|---|
| Title | Update on the recommended use of hepatitis B vaccine . |
| Variant title |
|
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 54 p. : col. chart |
| ISBN | 978-0-660-07209-8 |
| Catalogue number |
|
| Departmental catalogue number | 160293 |
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: